Apolipoprotein E allelic frequency altered in women with early-onset breast cancer

Tirtsa Porrata-Doria, Jaime L. Matta, Summer F. Acevedo

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Among women, the most prevalent type of cancer is breast cancer, affecting 1 out of every 8 women in the United States; in Puerto Rico, 70 out of every 100,000 will develop some type of breast cancer. Therefore, a better understand of the potential risk factors for breast cancer could lead to the development of early detection tools. A gene that has been proposed as a risk factor in several populations around the world is Apolipoprotein E (apoE). ApoE functions as a mechanism of transport for lipoproteins and cholesterol throughout the body, with 3 main isoforms present in humans (apoE2, apoE3, and apoE4). Whether or not apoE4 is a risk factor for breast cancer remains controversial. Previous studies have either included test subjects of all ages (20-80) or have focused on late-onset (after age 50) breast cancer; none has concentrated specifically on early-onset (aged 50 and younger) breast cancer. The objectives of this study was to examine (in a Puerto Rican population) the differences in the relative frequency of occurrence of apoE4 in non-breast cancer versus breast cancer patients and to examine, as well, the potential differences of same in early- versus late-onset patients. We found an increased frequency of apoE4 (odds ratio 2.15) only in early-onset breast cancer survivors, which is similar to the findings of those studies that combined or adjusted for age as well as for an association between apoE4 and decreased tumor size. ApoE is also a potential risk factor for long-term cognitive effects after chemotherapy and affects response to hormone replacement. Our data supports the theory that knowing the apoE genotype of women who are at risk of developing breast cancer may be beneficial, as such knowledge would aid in the prediction of tumor size and the development of treatment regimens.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalBreast Cancer: Basic and Clinical Research
Volume4
Issue number1
StatePublished - 2010

Fingerprint

Apolipoproteins E
Breast Neoplasms
Apolipoprotein E4
Apolipoprotein E2
Apolipoprotein E3
Puerto Rico
Age of Onset
Population
Survivors
Neoplasms
Protein Isoforms
Odds Ratio
Genotype
Hormones
Drug Therapy

Keywords

  • Apoe
  • Breast cancer
  • Early-onset
  • Puerto rican
  • Risk factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Apolipoprotein E allelic frequency altered in women with early-onset breast cancer. / Porrata-Doria, Tirtsa; Matta, Jaime L.; Acevedo, Summer F.

In: Breast Cancer: Basic and Clinical Research, Vol. 4, No. 1, 2010, p. 43-48.

Research output: Contribution to journalArticle

Porrata-Doria, Tirtsa ; Matta, Jaime L. ; Acevedo, Summer F. / Apolipoprotein E allelic frequency altered in women with early-onset breast cancer. In: Breast Cancer: Basic and Clinical Research. 2010 ; Vol. 4, No. 1. pp. 43-48.
@article{04979820b8b84d1fbb3f34fc936484fa,
title = "Apolipoprotein E allelic frequency altered in women with early-onset breast cancer",
abstract = "Among women, the most prevalent type of cancer is breast cancer, affecting 1 out of every 8 women in the United States; in Puerto Rico, 70 out of every 100,000 will develop some type of breast cancer. Therefore, a better understand of the potential risk factors for breast cancer could lead to the development of early detection tools. A gene that has been proposed as a risk factor in several populations around the world is Apolipoprotein E (apoE). ApoE functions as a mechanism of transport for lipoproteins and cholesterol throughout the body, with 3 main isoforms present in humans (apoE2, apoE3, and apoE4). Whether or not apoE4 is a risk factor for breast cancer remains controversial. Previous studies have either included test subjects of all ages (20-80) or have focused on late-onset (after age 50) breast cancer; none has concentrated specifically on early-onset (aged 50 and younger) breast cancer. The objectives of this study was to examine (in a Puerto Rican population) the differences in the relative frequency of occurrence of apoE4 in non-breast cancer versus breast cancer patients and to examine, as well, the potential differences of same in early- versus late-onset patients. We found an increased frequency of apoE4 (odds ratio 2.15) only in early-onset breast cancer survivors, which is similar to the findings of those studies that combined or adjusted for age as well as for an association between apoE4 and decreased tumor size. ApoE is also a potential risk factor for long-term cognitive effects after chemotherapy and affects response to hormone replacement. Our data supports the theory that knowing the apoE genotype of women who are at risk of developing breast cancer may be beneficial, as such knowledge would aid in the prediction of tumor size and the development of treatment regimens.",
keywords = "Apoe, Breast cancer, Early-onset, Puerto rican, Risk factor",
author = "Tirtsa Porrata-Doria and Matta, {Jaime L.} and Acevedo, {Summer F.}",
year = "2010",
language = "English (US)",
volume = "4",
pages = "43--48",
journal = "Breast Cancer: Basic and Clinical Research",
issn = "1178-2234",
publisher = "Libertas Academica Ltd.",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein E allelic frequency altered in women with early-onset breast cancer

AU - Porrata-Doria, Tirtsa

AU - Matta, Jaime L.

AU - Acevedo, Summer F.

PY - 2010

Y1 - 2010

N2 - Among women, the most prevalent type of cancer is breast cancer, affecting 1 out of every 8 women in the United States; in Puerto Rico, 70 out of every 100,000 will develop some type of breast cancer. Therefore, a better understand of the potential risk factors for breast cancer could lead to the development of early detection tools. A gene that has been proposed as a risk factor in several populations around the world is Apolipoprotein E (apoE). ApoE functions as a mechanism of transport for lipoproteins and cholesterol throughout the body, with 3 main isoforms present in humans (apoE2, apoE3, and apoE4). Whether or not apoE4 is a risk factor for breast cancer remains controversial. Previous studies have either included test subjects of all ages (20-80) or have focused on late-onset (after age 50) breast cancer; none has concentrated specifically on early-onset (aged 50 and younger) breast cancer. The objectives of this study was to examine (in a Puerto Rican population) the differences in the relative frequency of occurrence of apoE4 in non-breast cancer versus breast cancer patients and to examine, as well, the potential differences of same in early- versus late-onset patients. We found an increased frequency of apoE4 (odds ratio 2.15) only in early-onset breast cancer survivors, which is similar to the findings of those studies that combined or adjusted for age as well as for an association between apoE4 and decreased tumor size. ApoE is also a potential risk factor for long-term cognitive effects after chemotherapy and affects response to hormone replacement. Our data supports the theory that knowing the apoE genotype of women who are at risk of developing breast cancer may be beneficial, as such knowledge would aid in the prediction of tumor size and the development of treatment regimens.

AB - Among women, the most prevalent type of cancer is breast cancer, affecting 1 out of every 8 women in the United States; in Puerto Rico, 70 out of every 100,000 will develop some type of breast cancer. Therefore, a better understand of the potential risk factors for breast cancer could lead to the development of early detection tools. A gene that has been proposed as a risk factor in several populations around the world is Apolipoprotein E (apoE). ApoE functions as a mechanism of transport for lipoproteins and cholesterol throughout the body, with 3 main isoforms present in humans (apoE2, apoE3, and apoE4). Whether or not apoE4 is a risk factor for breast cancer remains controversial. Previous studies have either included test subjects of all ages (20-80) or have focused on late-onset (after age 50) breast cancer; none has concentrated specifically on early-onset (aged 50 and younger) breast cancer. The objectives of this study was to examine (in a Puerto Rican population) the differences in the relative frequency of occurrence of apoE4 in non-breast cancer versus breast cancer patients and to examine, as well, the potential differences of same in early- versus late-onset patients. We found an increased frequency of apoE4 (odds ratio 2.15) only in early-onset breast cancer survivors, which is similar to the findings of those studies that combined or adjusted for age as well as for an association between apoE4 and decreased tumor size. ApoE is also a potential risk factor for long-term cognitive effects after chemotherapy and affects response to hormone replacement. Our data supports the theory that knowing the apoE genotype of women who are at risk of developing breast cancer may be beneficial, as such knowledge would aid in the prediction of tumor size and the development of treatment regimens.

KW - Apoe

KW - Breast cancer

KW - Early-onset

KW - Puerto rican

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=77955478702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955478702&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77955478702

VL - 4

SP - 43

EP - 48

JO - Breast Cancer: Basic and Clinical Research

JF - Breast Cancer: Basic and Clinical Research

SN - 1178-2234

IS - 1

ER -